PDA

View Full Version : Dapagliflozin: New Hope for Patients with Type 2 Diabetes


Nikhil Jain
November 28th 13, 01:22 PM
According to a recent study published in the Diabetes Care journal, adding dapagliflozin to sitagliptin monotherapy reduces blood glucose levels in patients with type 2 diabetes.

People suffering from type 2 diabetes may sometimes require multiple therapies/combination therapy to manage their blood glucose levels. Dipeptidyl peptidase-4 (DPP-4) inhibitors are one of the most widely prescribed therapies used in combination with eithermetformin or sulfonylureas.

Read More Visit: https://www.icontrolmyhealth.org/news/combination-therapy-for-diabetes

John Doe
November 28th 13, 07:15 PM
Google Groups spam...

--
Nikhil Jain <theniklank gmail.com> wrote:

> X-Received: by 10.66.118.37 with SMTP id kj5mr14883932pab.17.1385641327548; Thu, 28 Nov 2013 04:22:07 -0800 (PST)
> X-Received: by 10.50.87.71 with SMTP id v7mr54538igz.11.1385641327430; Thu, 28 Nov 2013 04:22:07 -0800 (PST)
> Path: eternal-september.org!news.eternal-september.org!feeder.eternal-september.org!eu.feeder.erje.net!feeder.erje.net!u s.feeder.erje.net!news.snarked.org!newsfeed.news.u cla.edu!usenet.stanford.edu!y3no13992626pbx.0!news-out.google.com!9ni7156qaf.0!nntp.google.com!p15no6 70184qaj.0!postnews.google.com!glegroupsg2000goo.g ooglegroups.com!not-for-mail
> Newsgroups: rec.pets.cats.health+behav
> Date: Thu, 28 Nov 2013 04:22:06 -0800 (PST)
> Complaints-To: groups-abuse google.com
> Injection-Info: glegroupsg2000goo.googlegroups.com; posting-host=122.168.211.184; posting-account=U9loggoAAAAz2WHecYXI9Xb9la3cJVAX
> NNTP-Posting-Host: 122.168.211.184
> User-Agent: G2/1.0
> MIME-Version: 1.0
> Message-ID: <4ed4643f-0206-49f8-88b0-63246c8c3911 googlegroups.com>
> Subject: Dapagliflozin: New Hope for Patients with Type 2 Diabetes
> From: Nikhil Jain <theniklank gmail.com>
> Injection-Date: Thu, 28 Nov 2013 12:22:07 +0000
> Content-Type: text/plain; charset=ISO-8859-1
> Content-Transfer-Encoding: quoted-printable
> Xref: news.eternal-september.org rec.pets.cats.health+behav:11519
>
> According to a recent study published in the Diabetes Care journal, adding dapagliflozin to sitagliptin monotherapy reduces blood glucose levels in patients with type 2 diabetes.
>
> People suffering from type 2 diabetes may sometimes require multiple therapies/combination therapy to manage their blood glucose levels. Dipeptidyl peptidase-4 (DPP-4) inhibitors are one of the most widely prescribed therapies used in combination with eithermetformin or sulfonylureas.
>
> Read More Visit: https://www.icontrolmyhealth.org/news/combination-therapy-for-diabetes
>
>